Effect of GBT440, an R-State Stabilizer of Hemoglobin, on Hypoxic Maximal Exercise

被引:0
|
作者
Stewart, G. [1 ]
Chase, S. [1 ]
Cross, T. [1 ]
Ziegler, B. [1 ]
Joyner, M. [2 ]
Curry, T. [2 ]
Lehrer, J. [3 ]
Vlahakis, N. [3 ]
Johnson, B. [1 ]
机构
[1] Mayo Clin, Dept Cardiovasc Dis, Rochester, MN USA
[2] Mayo Clin, Dept Anesthesia & Perioperat Med, Rochester, MN USA
[3] Global Blood Therapeut, San Francisco, CA USA
关键词
D O I
暂无
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
A2367
引用
收藏
页数:2
相关论文
共 50 条
  • [1] Discovery of GBT440, an Orally Bioavailable R-State Stabilizer of Sickle Cell Hemoglobin
    Metcalf, Brian
    Chuang, Chihyuan
    Dufu, Kobina
    Patel, Mira P.
    Silva-Garcia, Abel
    Johnson, Carl
    Lu, Qing
    Partridge, James R.
    Patskovska, Larysa
    Patskovsky, Yury
    Almo, Steven C.
    Jacobson, Matthew P.
    Hua, Lan
    Xu, Qing
    Gwaltney, Stephen L., II
    Yee, Calvin
    Harris, Jason
    Morgan, Bradley P.
    James, Joyce
    Xu, Donghong
    Hutchaleelaha, Athiwat
    Paulvannan, Kumar
    Oksenberg, Donna
    Li, Zhe
    ACS MEDICINAL CHEMISTRY LETTERS, 2017, 8 (03): : 321 - 326
  • [2] Voxelotor (GBT440) produces interference in measurements of hemoglobin S
    Rutherford, Nicola J.
    Thoren, Katie L.
    Shajani-Yi, Zahra
    Colby, Jennifer M.
    CLINICA CHIMICA ACTA, 2018, 482 : 57 - 59
  • [3] Efficacy of GBT440 to Left-Shift the Oxy-Hemoglobin Dissociation Curve in Healthy Individuals and Preserve Arterial Saturation During Submaximal Hypoxic Exercise
    Stewart, G.
    Cross, T.
    Chase, S.
    Joyner, M.
    Curry, T.
    Isautier, J.
    Lehrer, J.
    Vlahakis, N. E.
    Johnson, B. D.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
  • [4] Voxelotor (GBT440), a Hemoglobin-Oxygen Affinity Modulator, Increases Oxygen Saturation in IPF Patients Who Desaturate with Exercise
    Lancaster, L.
    Collard, H. R.
    Dixon, S.
    Lasky, J. A.
    Lehrer-Graiwer, J.
    Noble, P. W.
    Scholand, M.
    Vlahakis, N. E.
    Cosgrove, G. P.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
  • [5] GBT440 reverses sickling of sickled red blood cells under hypoxic conditions in vitro
    Dufu, Kobina
    Oksenberg, Donna
    HEMATOLOGY REPORTS, 2018, 10 (02) : 35 - 39
  • [6] Effect of the Anti-Sickle Cell Drug GBT440 (Voxelotor) on Methemolobin
    Munoz, Aldo J.
    Cocco, Melanie J.
    BIOPHYSICAL JOURNAL, 2021, 120 (03) : 200A - 200A
  • [7] Doping control approach: Identification of equine in vitro metabolites of voxelotor (GBT440), a hemoglobin S polymerization inhibitor
    Subhahar, Michael Benedict
    Karakka Kal, Abdul Khader
    Philip, Moses
    Muhammed Ajeebsanu, Meleparappil
    Karatt, Tajudheen K.
    Perwad, Zubair
    RAPID COMMUNICATIONS IN MASS SPECTROMETRY, 2024, 38 (02)
  • [8] Probing the conformation of hemoglobin Presbyterian in the R-state
    Acharya, SA
    Malavalli, A
    Peterson, E
    Sun, PD
    Ho, C
    Prabhakaran, M
    Arnone, A
    Manjula, BN
    Friedman, JM
    JOURNAL OF PROTEIN CHEMISTRY, 2003, 22 (03): : 221 - 230
  • [9] A PERTURBED R-STATE RESPONSIBLE FOR HEMOGLOBIN OXIDATION
    ZHANG, L
    RIFKIND, JM
    LEVY, A
    BIOPHYSICAL JOURNAL, 1990, 57 (02) : A239 - A239
  • [10] GBT440 inhibits sickling of sickle cell trait blood under in vitro conditions mimicking strenuous exercise
    Dufu, Kobina
    Lehrer-Graiwer, Josh
    Ramos, Eleanor
    Oksenberg, Donna
    HEMATOLOGY REPORTS, 2016, 8 (03) : 37 - 41